MS is such a devasting disease that whenever a company comes out with positive
drug results its shares skyrocket. ELN shares did in the past, and so did ACOR but today there is a new player and its called OPEXA , symbol is OPXA or its warrants OPXAW
If ACOR can be any example to Opexa then this stock could easily become a multi bagger.
ACOR went from the $2's on positive results to $20's
and Novartis is trying to take advantage of Opexa , read today's seeking alpha news.
OPEXA should be given exposure so it has every chance to develop its drug for MS.
A cure is urgent for this devastating disease. I have lost 2 family members to it and have another 2 that are currently suffering from its devastating effects.